Ledger.Open graph →

SEC Form D · filed April 3, 2024

ImmunoGenesis, Inc

Offering

$66.5M

Sold

$44.4M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

HOUSTON, TX

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Michael Curran · Houston, TXDirector Ted Koutouzis · Los Angeles, CADirector Clifford Stocks · Seattle, WADirector James Barlow · Houston, TXExec · Director Jeremy Barton · Houston, TXExec Thomas Barton · Los Altos, CADirector Robert Stein · Washington, Washington, D.C.Director Federica O'Brien · Chagrin Falls, OHExec Federica Pericle · Houston, TXExec James Barlow · Houston, TXExec · Director Michael Curran · Houston, TXDirector Jeremy Barton · Houston, TXExec Thomas Barton · Los Altos, CADirector Robert Stein · New York, NYDirector Ted Koutouzis · Los Angeles, CADirector Federica O'Brien · Houston, TXExec Federica Pericle · Albuquerque, NMExec Clifford Stocks · Houston, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗